tacrolimus intravenous / Generic mfg.  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tacrolimus intravenous / Generic mfg.
2019-003710-13: A multi-center interventional study to assess pharmacokinetics, effectiveness and tolerability of prolonged-release Tacrolimus after Paediatric Kidney Transplantation

Not yet recruiting
3
30
Europe
Tablet, Capsule, hard, Envarsus®, Prograf
University Hospital Essen, Chiesi GmbH
Caucasian paediatric kidney transplant recipients, Caucasian paediatric kidney transplant recipients, Diseases [C] - Immune System Diseases [C20]
 
 
NCT00679042: Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol

Active, not recruiting
3
21
US
Islets of Langerhans transplantation, Islets of Langerhan (Islets), Basiliximab (Simulect®), Tacrolimus (Prograf®), Sirolimus (Rapamune®), Etanercept(Enbrel®), Exenatide (Byetta®)
CellTrans Inc.
Type 1 Diabetes Mellitus
07/17
06/26
CATHY, NCT04976699: CD24Fc for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)

Active, not recruiting
3
11
US
CD24Fc, Human CD24 and human IgG Fc Fusion Protein, Placebo, Saline, Methotrexate, Trexall, Tacrolimus, FK506, Prograf
Merck Sharp & Dohme Corp.
Hematopoietic Stem Cell Transplantation, Acute Graft Versus Host Disease, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes
11/21
11/21

Download Options